BDBM50207804 20-(pyrrolidin-1-yl)-4,14,19,26-tetraazaheptacyclo[24.6.1.1^{7,14}.1^{18,22}.0^{2,6}.0^{8,13}.0^{27,32}]pentatriaconta-1(33),2(6),7(35),8(13),9,11,18,20,22(34),27(32),28,30-dodecaene-3,5-dione::CHEMBL397771

SMILES O=C1NC(=O)C2=C1c1cn(CCCc3cc(CCCn4cc2c2ccccc42)nc(c3)N2CCCC2)c2ccccc12

InChI Key InChIKey=LXUXFJHDJVXMGK-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50207804   

TargetGlycogen synthase kinase-3 beta(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50207804(20-(pyrrolidin-1-yl)-4,14,19,26-tetraazaheptacyclo...)
Affinity DataIC50: 11nMAssay Description:Inhibition of human recombinant GSK3-betaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50207804(20-(pyrrolidin-1-yl)-4,14,19,26-tetraazaheptacyclo...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of human recombinant PKCbeta2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed